Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer
NCT02269683 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2016-06-01
Summary
The present randomized controlled trial evaluates the incidence of R1 resections in patients undergoing robotic distal pancreatectomy compared to the laparoscopic technique.
Conditions
- Pancreatic Tumor
Interventions
- PROCEDURE
-
Robot-assisted distal pancreatectomy
- PROCEDURE
-
Laparoscopic distal pancreatectomy
Sponsors & Collaborators
-
Technische Universität Dresden
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2015-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection
NCT01278368 ·Status: COMPLETED ·Phase: NA
-
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
NCT00524069 ·Status: WITHDRAWN ·Phase: NA
-
Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
NCT06677762 ·Status: NOT_YET_RECRUITING
-
RNA Precision Oncology in Advanced Pancreatic Cancer
NCT04476537 ·Status: TERMINATED ·Phase: NA
-
A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma
NCT05997147 ·Status: UNKNOWN
-
Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676 ·Status: ENROLLING_BY_INVITATION
-
Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
NCT00233415 ·Status: COMPLETED ·Phase: PHASE2
-
Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer
NCT00003085 ·Status: TERMINATED ·Phase: PHASE2
-
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
NCT01045941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid
NCT04777604 ·Status: NOT_YET_RECRUITING
-
Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer
NCT01027221 ·Status: COMPLETED ·Phase: NA
-
A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection
NCT03038477 ·Status: WITHDRAWN ·Phase: PHASE2
-
Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
NCT01017822 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Tumor Registry Pancreatic Cancer
NCT02089269 ·Status: COMPLETED
-
Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids
NCT04821219 ·Status: WITHDRAWN ·Phase: NA
-
The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
NCT03747588 ·Status: RECRUITING ·Phase: NA
-
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
NCT01234935 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
NCT02707328 ·Status: TERMINATED ·Phase: PHASE1
-
Neoadjuvant Treatment in Resectable Pancreatic Cancer
NCT01900327 ·Status: TERMINATED ·Phase: PHASE3
-
Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer
NCT03199144 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
NCT02707315 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
NCT01760694 ·Status: TERMINATED ·Phase: NA
-
A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
NCT03840460 ·Status: UNKNOWN
-
Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer
NCT01419002 ·Status: TERMINATED ·Phase: PHASE3
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN